| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Joanne Barnes | Q44019308 |
| P2093 | author name string | Simon Gibbons | |
| J David Phillipson | |||
| Linda A Anderson | |||
| P2860 | cites work | Evidence from two classic irritation tests for an anti-inflammatory action of a natural extract, Echinacina B. | Q54424483 |
| Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial. | Q55033009 | ||
| Patuletin-3-O-Rutinoside from the Aerial Parts of Echinacea angustifolia | Q56777160 | ||
| Echinacoside and caffeoyl conjugates protect collagen from free radical-induced degradation: a potential use of Echinacea extracts in the prevention of skin photodamage | Q59195777 | ||
| Gas chromatography-mass spectral analysis of roots ofEchinacea species and classification by multivariate data analysis | Q104374896 | ||
| Effects of Root Drying Temperature and Moisture Content on the Levels of Active Ingredients in Echinacea Roots | Q104386017 | ||
| Standardization ofEchinacea purpureaExpressed Juice with Reference to Cichoric Acid and Alkamides | Q104388827 | ||
| Bioactivity of alkamides isolated from Echinacea purpurea (L.) Moench | Q28193132 | ||
| Oral administration of freshly expressed juice of Echinacea purpurea herbs fail to stimulate the nonspecific immune response in healthy young men: results of a double-blind, placebo-controlled crossover study | Q28198183 | ||
| The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo | Q28241382 | ||
| Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial | Q28266919 | ||
| Medicinal properties of Echinacea: a critical review | Q33845969 | ||
| Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. | Q33974381 | ||
| Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial | Q33975378 | ||
| Ineffectiveness of echinacea for prevention of experimental rhinovirus colds | Q33979856 | ||
| Immunomodulation with echinacea - a systematic review of controlled clinical trials | Q34034578 | ||
| Does the extract of the plant Echinacea purpurea influence the clinical course of recurrent genital herpes? | Q34170026 | ||
| Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways | Q34369966 | ||
| Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers | Q34606089 | ||
| TLC and HPLC Analysis of Alkamides in Echinacea Drugs1,2. | Q34607522 | ||
| Acute disseminated encephalomyelitis after parenteral therapy with herbal extracts: a report of two cases | Q35459554 | ||
| Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies. | Q35802401 | ||
| Benefit-risk assessment of the squeezed sap of the purple coneflower (Echinacea purpurea) for long-term oral immunostimulation. | Q38063601 | ||
| Acute drought stress and plant age effects on alkamide and phenolic acid content in purple coneflower roots | Q39031592 | ||
| Virus-inhibition by echinacea purpurea (author's transl) | Q40137166 | ||
| Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study | Q40539304 | ||
| The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study | Q40615497 | ||
| Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial | Q40835053 | ||
| Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea | Q40979348 | ||
| An alternative medicine study of herbal effects on the penetration of zona-free hamster oocytes and the integrity of sperm deoxyribonucleic acid | Q41610965 | ||
| Inhibition of human sperm motility by specific herbs used in alternative medicine | Q41613881 | ||
| Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus | Q42539361 | ||
| Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea | Q43538128 | ||
| Antiviral activity of characterized extracts from echinacea spp. (Heliantheae: Asteraceae) against herpes simplex virus (HSV-I). | Q43605056 | ||
| Comparison of chemical components and antioxidants capacity of different Echinacea species | Q43655086 | ||
| Echinacea purpurea and melatonin augment natural-killer cells in leukemic mice and prolong life span | Q43663606 | ||
| Absorption of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral application of Echinacea purpurea tincture | Q43824115 | ||
| Anti-inflammatory and cicatrizing activity of Echinacea pallida Nutt. root extract. | Q43860528 | ||
| Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats | Q43866771 | ||
| Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy--a pilot study | Q43947551 | ||
| Transport of alkamides from Echinacea species through Caco-2 monolayers | Q44023275 | ||
| Critical hypokalemic renal tubular acidosis due to Sj�gren's syndrome: association with the purported immune stimulant echinacea | Q44436655 | ||
| The American coneflower: a prophylactic role involving nonspecific immunity | Q44628724 | ||
| Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model. | Q44746150 | ||
| Can an herbal preparation of echinacea, propolis, and vitamin C reduce respiratory illnesses in children? | Q44781922 | ||
| In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. | Q45146006 | ||
| Nonspecific immunostimulation with low doses of cyclophosphamide (LDCY), thymostimulin, and Echinacea purpurea extracts (echinacin) in patients with far advanced colorectal cancers: preliminary results | Q45800757 | ||
| Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children | Q48025565 | ||
| Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. | Q54236242 | ||
| Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. | Q54304780 | ||
| P433 | issue | 8 | |
| P921 | main subject | pharmacology | Q128406 |
| Echinacea purpurea | Q272661 | ||
| Echinacea angustifolia | Q1062627 | ||
| Echinacea pallida | Q1813728 | ||
| P304 | page(s) | 929-954 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | Journal of Pharmacy and Pharmacology | Q10532762 |
| P1476 | title | Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties | |
| P478 | volume | 57 |
| Q41234878 | A C-banded karyotype of mitotic chromosomes in diploid purple coneflower (Echinacea purpurea L.). |
| Q92600630 | A strategy for test article selection and phytochemical characterization of Echinacea purpurea extract for safety testing |
| Q36631506 | Alcohol extracts of Echinacea inhibit production of nitric oxide and tumor necrosis factor-alpha by macrophages in vitro |
| Q34278613 | Alkamid database: Chemistry, occurrence and functionality of plant N-alkylamides. |
| Q35971775 | Alkamide stability in Echinacea purpurea extracts with and without phenolic acids in dry films and in solution |
| Q28302804 | Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects |
| Q90270091 | An Ultrasensitive Non-Enzymatic Sensor for Quantitation of Anti-Cancer Substance Chicoric Acid Based on Bimetallic Nanoalloy with Polyetherimide-Capped Reduced Graphene Oxide |
| Q35919968 | An overview of the evidence and mechanisms of herb-drug interactions. |
| Q30382531 | Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV) |
| Q35494999 | Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases |
| Q35685529 | Bauer ketones 23 and 24 from Echinacea paradoxa var. paradoxa inhibit lipopolysaccharide-induced nitric oxide, prostaglandin E2 and cytokines in RAW264.7 mouse macrophages |
| Q92630140 | Biological Activity of New Cichoric Acid-Metal Complexes in Bacterial Strains, Yeast-Like Fungi, and Human Cell Cultures In Vitro |
| Q38235469 | Biotechnological production of caffeic acid derivatives from cell and organ cultures of Echinacea species |
| Q36771776 | Chicoric acid binds to two sites and decreases the activity of the YopH bacterial virulence factor |
| Q21131316 | Chicoric acid: chemistry, distribution, and production |
| Q34517159 | Commonly Used Dietary Supplements on Coagulation Function during Surgery |
| Q38323894 | Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 2: Echinacea purpurea-Lavandula angustifolia. |
| Q36492104 | Cytokine- and interferon-modulating properties of Echinacea spp. root tinctures stored at -20 degrees C for 2 years |
| Q36495159 | Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallida. |
| Q42805448 | Dodeca-2(E),4(E)-dienoic acid isobutylamide enhances glucose uptake in 3T3-L1 cells via activation of Akt signaling |
| Q38974893 | Drug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products. |
| Q39664418 | Echinacea and trypanasomatid parasite interactions: growth-inhibitory and anti-inflammatory effects of Echinacea |
| Q57279724 | Echinacea biotechnology: advances, commercialization and future considerations |
| Q37157352 | Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation. |
| Q34074274 | Echinacea purpurea (L.) Moench modulates human T-cell cytokine response. |
| Q40379886 | Echinacea purpurea Extract Polarizes M1 Macrophages in Murine Bone Marrow-Derived Macrophages Through the Activation of JNK. |
| Q34467036 | Echinacea purpurea aerial extract alters course of influenza infection in mice. |
| Q42812590 | Echinacea purpurea root extract enhances the adipocyte differentiation of 3T3-L1 cells |
| Q36126286 | Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects |
| Q35635920 | Echinacea purpurea: Pharmacology, phytochemistry and analysis methods. |
| Q37134477 | Echinacea sanguinea and Echinacea pallida extracts stimulate glucuronidation and basolateral transfer of Bauer alkamides 8 and 10 and ketone 24 and inhibit P-glycoprotein transporter in Caco-2 cells |
| Q36627223 | Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells |
| Q37198076 | Echinacea tennesseensis ethanol tinctures harbor cytokine- and proliferation-enhancing capacities |
| Q33752069 | Echinacea-induced cytosolic Ca2+ elevation in HEK293. |
| Q55617078 | Echinacea—A Source of Potent Antivirals for Respiratory Virus Infections. |
| Q39326895 | Effect of SAMITAL® in the treatment of chemotherapy-induced mucositis in adult oncohematological patients |
| Q37088260 | Effects of chemically characterized fractions from aerial parts of Echinacea purpurea and E. angustifolia on myelopoiesis in rats |
| Q43983228 | Effects of cichoric acid extract from Echinacea purpurea on collagen-induced arthritis in rats |
| Q37421665 | Endogenous levels of Echinacea alkylamides and ketones are important contributors to the inhibition of prostaglandin E2 and nitric oxide production in cultured macrophages. |
| Q34306204 | Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review |
| Q40406513 | Evaluation of immunomodulatory and anti-inflammatory effects and phytochemical screening of Alternanthera tenella Colla (Amaranthaceae) aqueous extracts. |
| Q46521143 | Free amino acids in botanicals and botanical preparations. |
| Q24656624 | Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics |
| Q34483552 | Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients |
| Q36276879 | Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patients |
| Q38543351 | Herbal hepatotoxicity: current status, examples, and challenges. |
| Q41726314 | Hyperspectral imaging and chemometric modeling of echinacea - a novel approach in the quality control of herbal medicines. |
| Q64978528 | In vitro and in vivo studies of the immunomodulatory effect of Echinacea purpurea on dendritic cells. |
| Q39545238 | In vitro inhibition of Eimeria tenella invasion of epithelial cells by phytochemicals. |
| Q51032481 | In vivo screening of five phytochemicals/extracts and a fungal immunomodulatory protein against colibacillosis in broilers. |
| Q44689414 | In vivo screening of four phytochemicals/extracts and a fungal immunomodulatory protein against an Eimeria acervulina infection in broilers. |
| Q42005590 | Induction of tetraploids from petiole explants through colchicine treatments in Echinacea purpurea L. |
| Q92097925 | Laboratory-derived formulations of Echinacea angustifolia roots lack preventive and treatment efficacy against experimental rhinovirus infections of healthy volunteers |
| Q39403596 | Liver immunology and herbal treatment. |
| Q28066772 | Medicinal plants--prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review |
| Q37052516 | Metabolic profiling of echinacea genotypes and a test of alternative taxonomic treatments |
| Q49484250 | MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2. |
| Q91671179 | Modulation of Diabetes Mellitus-Induced Male Rat Reproductive Dysfunction with Micro-Nanoencapsulated Echinacea purpurea Ethanol Extract |
| Q36050847 | Mucosal and blood-brain barrier transport kinetics of the plant N-alkylamide spilanthol using in vitro and in vivo models. |
| Q38913421 | Novel TRAIL sensitizer Taraxacum officinale F.H. Wigg enhances TRAIL-induced apoptosis in Huh7 cells |
| Q37283479 | Overview of Botanical Status in EU, USA, and Thailand |
| Q36478368 | PHENETIC COMPARISON OF SEVEN Echinacea SPECIES BASED ON IMMUNOMODULATORY CHARACTERISTICS |
| Q38574619 | Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences |
| Q33795072 | Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects |
| Q47160659 | Plant-endophytes interaction influences the secondary metabolism in Echinacea purpurea (L.) Moench: an in vitro model. |
| Q47198730 | Possible Mechanisms of the Prevention of Doxorubicin Toxicity by Cichoric Acid-Antioxidant Nutrient |
| Q34485025 | Quantification of phenylpropanoids in commercial Echinacea products using TLC with video densitometry as detection technique and ANN for data modelling. |
| Q42487432 | Rabbit dietary supplementation with pale purple coneflower. 1. Effects on the reproductive performance and immune parameters of does |
| Q40979411 | Rabbit dietary supplementation with pale purple coneflower. 2. Effects on the performances, bacterial community, blood parameters and immunity of growing rabbits. |
| Q35645820 | Randomised, double blind, placebo-controlled trial of echinacea supplementation in air travellers |
| Q41839742 | Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides Do Not Induce CYP3A4 mRNA Expression |
| Q33631686 | Secondary Metabolites from Fungal Endophytes of Echinacea purpurea Suppress Cytokine Secretion by Macrophage-Type Cells |
| Q47896744 | Simultaneous Determination of Seven Phenolic Acids in Rat Plasma Using UHPLC-ESI-MS/MS after Oral Administration of Echinacea purpurea Extract. |
| Q92753246 | Supplementation of Plants with Immunomodulatory Properties during Pregnancy and Lactation-Maternal and Offspring Health Effects |
| Q36120667 | Synthesis and natural distribution of anti-inflammatory alkamides from Echinacea. |
| Q42641602 | The anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteers. |
| Q49108941 | The effects of an Echinacea preparation on synaptic transmission and the firing properties of CA1 pyramidal cells in the hippocampus |
| Q92215521 | The influence of Echinacea purpurea leaf microbiota on chicoric acid level |
| Q39657299 | The potential use of Echinacea in acne: control of Propionibacterium acnes growth and inflammation |
| Q36002697 | The synthesis and natural distribution of the major ketone constituents in Echinacea pallida |
| Q93111390 | Tissue specificity and differential effects on in vitro plant growth of single bacterial endophytes isolated from the roots, leaves and rhizospheric soil of Echinacea purpurea |
| Q35990811 | Year-and-a-half old, dried Echinacea roots retain cytokine-modulating capabilities in an in vitro human older adult model of influenza vaccination. |
Search more.